Michel, Maurice; Labenz, Christian; Galle, Peter R. et al.
PREVALENCE OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE, AND ITS IMPACT ON HEALTH-RELATED QUALITY OF LIFE IN PEOPLE LIVING WITH HIVHEPATOLOGY. Bd. 76. 2022 S. S719-S720
De Lorenzi, Federica; Rizzo, Larissa Yokota; Daware, Rasika et al.
Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micellesDRUG DELIVERY AND TRANSLATIONAL RESEARCH. 2022
Simpson, Missy; Alexander, Leigh; Ratziu, Vlad et al.
PROTEOMIC MARKERS OF CARDIOVASCULAR AND METABOLIC HEALTH IN AT-RISK NASHHEPATOLOGY. Bd. 76. 2022 S. S608-S609
Mettler, Esther; Fottner, Christian; Bakhshandeh, Neda et al.
Quantitative Analysis of Plasma Cell-Free DNA and Its DNA Integrity and Hypomethylation Status as Biomarkers for Tumor Burden and Disease Progression in Patients with Metastatic Neuroendocrine NeoplasiasCANCERS. Bd. 14. H. 4. 2022
Stoehr, Fabian; Kloeckner, Roman; Dos Santos, Daniel Pinto et al.
Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC-A Proof-of-Concept StudyCANCERS. Bd. 14. H. 24. 2022
Graf, Christiana; Dietz, Julia; Muellhaupt, Beat et al.
REAL-LIFE EFFECTIVENESS OF VOXILAPREVIR/VELPATASVIR/SOFOSBUVIR IN HEPATITIS C PATIENTS PREVIOUSLY TREATED WITH DIRECT-ACTING ANTIVIRAL AGENTS (DAA)HEPATOLOGY. Bd. 76. 2022 S. S48-S49
Welland, Sabrina; Leyh, Catherine; Finkelmeier, Fabian et al.
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter StudyLIVER CANCER. Bd. 11. H. 3. 2022 S. 219-232
Lazarus, Jeffrey V.; Castera, Laurent; Mark, Henry et al.
REAL-WORLD EVIDENCE ON NON-INVASIVE TESTS AND ASSOCIATED CUT-OFFS USED TO ASSESS FIBROSIS IN ROUTINE CLINICAL PRACTICEHEPATOLOGY. Bd. 76. 2022 S. S818-S820
Moehler, Markus; Hoegner, Anica; Wagner, Anna D. et al.
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinomaEUROPEAN JOURNAL OF CANCER. Bd. 176. 2022 S. 13-29
Schattenberg, Jorn M.; Emrich, Tilman
Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?EUROPEAN RADIOLOGY. Bd. 32. H. 3. 2022 S. 1757-1759